TMEM105 and pancreatic neoplasm: To further demonstrate the role of TMEM105 in regulating pancreatic cancer growth and disulfidptosis through β-catenin, Mia PaCa-2 and SW-1990 were treated with β-catenin activator SKL2001 (20μM) after TMEM105 knockdown.